Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 19,496 shares at $115.24 ($2.2M) on 2025-10-30, disclosed to the SEC on 2025-11-03.
Scheduled sale ($2.2M) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.24 | 9,748 | $1.1M | 50.0% |
| 2 | $115.24 | 9,748 | $1.1M | 50.0% |
| Total | $115.24 avg | 19,496 | $2.2M | 100% |
| Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |
| RYTM | SELL | 2025-08-25 | $838K | — | Filing → |